LabCorp (LH)
| Market Cap | 27.72B |
| Revenue (ttm) | 15.32B |
| Net Income (ttm) | 2.64B |
| Shares Out | 97.60M |
| EPS (ttm) | 26.89 |
| PE Ratio | 10.55 |
| Forward PE | 12.82 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 23 |
| Last Price | $283.77 |
| Previous Close | $281.10 |
| Change ($) | 2.67 |
| Change (%) | 0.95% |
| Day's Open | 281.98 |
| Day's Range | 281.98 - 285.82 |
| Day's Volume | 627,870 |
| 52-Week Range | 170.05 - 285.82 |
LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
LabCorp's (LH) second-quarter base-business performance is expected to have registered a faster recovery rate compared to the first quarter.
LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LH vs. CNMD: Which Stock Is the Better Value Option?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...
Investors are optimistic about LabCorp (LH) backed by strong diagnostic arm growth and improvement in base business.
LabCorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here are five out of the 10 stocks, ASO, LB, PTR, LH, and HIBB, based on hybrid GARP investment strategy.
LabCorp's (LH) new test expands the company's leadership in bringing testing solutions for new precision medicines used to treat patients with lung cancer.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2021 before the market opens on Thursday, July...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp® (NYSE: LH), a leading global life sciences company, today announced the availability of therascreen® KRAS PCR Mutation Analysis, a companion diagnostic to ide...
LH vs. CNMD: Which Stock Is the Better Value Option?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...
Value investors may want to consider the stocks listed below, as they have low price-sales ratios (compared to the S&P 500), good profitability and stable financial situations.
The SARS-CoV-2 Research Sequencing Panel will help LabCorp (LH) sequence thousands of complete coronavirus genomes each week from positive patient samples.
NEWTON, Mass., June 22, 2021 /PRNewswire/ -- Molecular Loop Biosciences, Inc. , a company redefining the simplicity of targeted sequencing, announced today that its SARS-CoV-2 Research Sequencing Panel ...
These companies dominate a vital medical industry niche, and their valuations are near their all-time lows.
LabCorp (LH) enables evidence-based, personalized treatment suggestions based on the genomic profiling of a patient's solid tumor with the launch of new test.
BUFFALO, N.Y., June 14, 2021 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, and OmniSeq, a CAP-accredited, molecular diagnostic innovation of Roswell Park Comprehensive Canc...
These seven healthcare stocks are in a good position to take off as baby boomers continue to age into retirement. The post 7 Healthcare Stocks to Buy for Changing Demographics appeared first on Investor...
According to LabCorp (LH), the on-demand delivery option is useful for individuals showing symptoms of COVID-19 infection who want to be tested without potentially infecting others.
BURLINGTON, N.C. & DEERFIELD, Ill.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company today announced that Pixel by Labcorp® COVID-19 PCR Test Home Collection Kits are now in 6...
According to the GuruFocus All-in-One Screener, a Premium feature, the following companies have high business predictability ratings and wide margins of safety as of June 8.
MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.
Michael Price (Trades, Portfolio)'s MFP Investors LLC recently disclosed its portfolio updates for the first quarter of 2021, which ended on March 21.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the virtual 2021 American Soc...
LabCorp (LH) claims this to be the largest known COVID-related study in terms of specimen volume.
Like many other diagnostics and drug development companies, Laboratory Corp. of America Holdings ( LH , Financial) saw its base business decline as Covid-19 took hold. Fewer patients sought routine medi...
BURLINGTON, N.C.--(BUSINESS WIRE)--Nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2 proteins for at least 10 months, according to a new Labcorp (NYSE: LH) analysis ...
Jana Partners (Trades, Portfolio), a New York-based investment firm, disclosed this week that its top five trades during the first quarter included the reduction in its holdings in Perspecta Inc. ( PRSP...
If seeking for high return investments amid non-cyclical stocks, investors could be interested in the three companies listed below, as their earnings yields (as calculated via Joel Greenblatt ( Joel Gre...
The new laboratory by LabCorp (LH) is set to enable faster data turnaround for early phase trials in Asia-Pacific markets.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its drug development offering in the Asia-Pacific region with the addition...
LabCorp (LH) becomes the first major commercial laboratory to offer a COVID-19 PCR Test Home Collection Kit for children and adolescents.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat a...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (E...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH) (“Labcorp”) announced today that it has priced its offering of $1,000,000,000 in senior notes. The offering consists of two tranches: $500,000,000 a...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH) (“Labcorp”) announced today that it plans to offer, subject to market and other conditions, senior notes that are expected to be issued in two tranc...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, is working with the U.S. Department of Health and Human Services (HHS) to raise awareness of potentially li...
LabCorp's (LH) Walgreens-partnership expands to include new integrated digital experiences.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and inte...
Test Available Exclusively through Labcorp in the U.S. and Canada
LabCorp's (LH) raises 2021 guidance but projects significant sinking of COVID-related testing revenues.
LabCorp (LH) delivered earnings and revenue surprises of 20.08% and 7.39%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading life sciences company, today announced results for the first quarter ended March 31, 2021 and raised 2021 guidance. “We delivered very st...
LabCorp (LH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
With respect to LabCorp's (LH) COVID-19 testing services wing, although extensive vaccine rollouts are ongoing, the resurgence of the virus might have once again boosted testing demand in Q1.
LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
About LH
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides ... [Read more...]
| Industry Diagnostics & Research | Founded 1971 |
| CEO Adam Schechter | Employees 70,000 |
| Stock Exchange NYSE | Ticker Symbol LH |
Financial Performance
In 2020, LabCorp's revenue was $13.98 billion, an increase of 20.98% compared to the previous year's $11.55 billion. Earnings were $1.56 billion, an increase of 88.89%.
Analyst Forecasts
According to 18 analysts, the average rating for LabCorp stock is "Buy." The 12-month stock price forecast is 305.92, which is an increase of 7.81% from the latest price.